The significant increase of FcγRIIIA (CD16), a sensitive marker, in patients with coronary heart disease

Gene

Volumn 504, Issue 2, 2012, Pages 284-287

  Huang, Ye ^a   Yin, Huijun ^a   Wang, Jingshang ^a   Ma, Xiaojuan ^a   Zhang, Ying ^a   Chen, Keji ^a  

^a XIYUAN HOSPITAL   (China)

Author keywords

CHD; Fc RIIIA; Inflammation; Monocytes

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; COLONY STIMULATING FACTOR 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; LEUKOCYTE; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BASE SEQUENCE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY DISEASE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GPI-LINKED PROTEINS; HUMANS; RECEPTORS, IGG;

EID: 84862762533     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.05.017     Document Type: Article

References (28)

1. Bazil V., Strominger J.L. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 1991, 147:1567-1574.
2. Belge K.U., et al. The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF. J. Immunol. 2002, 168:3536-3542.
3. Braunwald E., et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on the management of patients with unstable angina). J. Am. Coll. Cardiol. 2002, 40:1366-1374.
4. Buckley D.I., Fu R., Freeman M., Rogers K., Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009, 151:483-495.
5. Cairns A.P., Crockard A.D., Bell A.L. The CD14+CD16+ monocyte subset in rheumatoid arthritis and systemic lupus erythematosus. Rheumatol. Int. 2002, 21:189-192.
6. de Bont N., et al. LPS-induced release of IL-1 beta, IL-1 Ra, IL-6, and TNF-alpha in whole blood from patients with familial hypercholesterolemia: no effect of cholesterol-lowering treatment. J. Interferon Cytokine Res. 2006, 26:101-107.
7. Deo Y.M., Graziano R.F., Repp R., van de Winkel J.G. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies. Immunol. Today 1997, 18:127-135.
8. Devaraj S., Yun J.M., Duncan-Staley C., Jialal I. C-reactive protein induces M-CSF release and macrophage proliferation. J. Leukoc. Biol. 2009, 85:262-267.
9. Fingerle G., Pforte A., Passlick B., Blumenstein M., Ströbel M., Zieglar-Heitbrock H.W. The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 1993, 82:3170-3176.
10. Frankenberger M., Sternsdorf T., Pechumer H., Pforte A., Ziegler-Heitbrock H.W. Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis. Blood 1996, 87:373-377.
11. Gibbons R.J., et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with chronic stable angina). Circulation 1999, 99:2829-2848.
12. Huang Y., Yin H., Wang J., Liu Q., Wu C., Chen K. Aberrant expression of FcγRIIIA (CD16) contributes to the development of atherosclerosis. Gene 2012, 498:91-95.
13. Johnson J., et al. Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment. Circulation 2005, 111:1422-1430.
14. Kaptoge S., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
15. Krüger C., et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 1991, 85:297-301.
16. Lawson C., Wolf S. ICAM-1 signaling in endothelial cells. Pharmacol. Rep. 2009, 61:22-32.
17. Masuda A., et al. Role of Fc receptors as a therapeutic target. Inflamm. Allergy Drug Targets 2009, 8:80-86.
18. Munn D.H., Garnick M.B., Cheung N.K. Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates. Blood 1990, 75:2042-2048.
19. Nockher W.A., Scherberich J.E. Expanded CD14+CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis. Infect. Immun. 1998, 66:2782-2790.
20. Nockher W.A., Bergmann L., Scherberich J.E. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 1994, 98:369-374.
21. Pepys M.B., Hirschfield G.M. C-reactive protein: a critical update. J. Clin. Invest. 2003, 111:1805-1812.
22. Randolph G.J. The fate of monocytes in atherosclerosis. J. Thromb. Haemost. 2009, 7(Suppl. 1):28-30.
23. Shantsila E., Lip G.Y. Monocytes in acute coronary syndromes. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1433-1438.
24. Thieblemont N., Weiss L., Sadeghi H.M., Estcourt C., Haeffner-Cavaillon N. CD14 low CD16 high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection. Eur. J. Immunol. 1995, 25:3418-3424.
25. Watanabe Y., et al. Role of macrophage colony-stimulating factor in the initial process of atherosclerosis. Ann. N. Y. Acad. Sci. 1995, 748:357-364.
26. Willerson J.T., Ridker P.M. Inflammation as a cardiovascular risk factor. Circulation 2004, 109(Suppl. 1):II2-II10.
27. Yin H.J., Ma X.J., Jiang Y.R., Shi D.Z., Chen K.J. Investigation of gene expression profiles in coronary heart disease and functional analysis of target gene. Chin. Sci. Bull. 2009, 54:1-7.
28. Young D.A., Lowe L.D., Clark S.C. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture: analysis of macrophage antibody-dependent cellular cytotoxicity. J. Immunol. 1990, 145:607-615.